NUAK2 inhibitors, KHKI-01128 and KHKI-01215, suppress YAP transcriptional activity, thereby reducing CRC cell proliferation and inducing apoptosis in SW480 cells (124). Here, YAP1 is linked to colorectal carcinoma.